Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,749 | 78,637 | 86,571 | 87,909 | 92,629 |
| Receivables | 20,588 | 22,454 | 18,874 | 19,118 | 18,702 |
| Inventories | 8,448 | 5,065 | 7,113 | 5,187 | 8,945 |
| Other current assets | 3,482 | 4,955 | 2,302 | 3,570 | 3,730 |
| TOTAL | $108,267 | $111,111 | $114,860 | $115,784 | $124,006 |
| Non-Current Assets | |||||
| PPE Net | 153 | 224 | 296 | 375 | 511 |
| Intangibles | 2,543 | 2,631 | 2,720 | 2,809 | 2,898 |
| Other Non-Current Assets | 12,352 | 13,903 | 11,008 | 13,428 | 10,030 |
| TOTAL | $15,048 | $16,758 | $14,024 | $16,612 | $13,439 |
| Total Assets | $123,315 | $127,869 | $128,884 | $132,396 | $137,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,728 | 6,060 | 7,610 | 7,252 | 8,843 |
| Accrued Expenses | 9,989 | 13,166 | 13,304 | 16,152 | 16,222 |
| TOTAL | $17,605 | $20,128 | $21,812 | $24,233 | $25,920 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,521 | 6,756 | 6,922 | 3,482 | 3,696 |
| TOTAL | $6,521 | $6,756 | $6,922 | $3,482 | $3,696 |
| Total Liabilities | $24,126 | $26,884 | $28,734 | $27,715 | $29,616 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,883 | 43,777 | 43,622 | 43,620 | 43,678 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -464,099 | -457,470 | -456,482 | -448,735 | -442,433 |
| Other shareholders' equity | 848 | 449 | 1,849 | 1,043 | 1,025 |
| TOTAL | $99,189 | $100,985 | $100,150 | $104,681 | $107,829 |
| Total Liabilities And Equity | $123,315 | $127,869 | $128,884 | $132,396 | $137,445 |